A study of fructo oligosaccharides in the prevention of travellers' diarrhoea

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 8, 2001, Pages 1139-1145

  Cummings, J H ^a   Christie, S ^b   Cole, T J ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; HIGH RISK POPULATION; HUMAN; LACTOBACILLUS BIFIDUS; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRAVEL; TRAVELLER DIARRHEA; TREATMENT OUTCOME; UNITED KINGDOM; WELLBEING;

EID: 0034914354     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01043.x     Document Type: Article

References (27)

1. Traveller's diarrhoea
2. Travellers' diarrhoea
3. Travellers' diarrhoea
4. Travel medicine - Prevention based on epidemiological data
5. Epidemiology of traveller's diarrhoea
6. Travellers' diarrhoea
7. Epidemiologic studies of travellers' diarrhoea, severe gastrointestinal infections, and cholera
8. Epidemiology of travellers' diarrhoea and relative importance of various pathogens
9. Travellers' diarrhoea: Epidemiology, microbiology, prevention, and therapy
10. Study of infectious intestinal disease in England: Rates in the community, presenting to general practice, and reported to national surveillance
11. Gastrointestinal infections presenting in general practice in Scotland
12. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine
13. Regulatory effects of bifidobacteria on the growth of other colonic bacteria
14. Colonization resistance of the digestive tract: Clinical consequences and implications
15. Review of probiotics available to modify gastrointestinal flora
16. Review article: The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease
17. Prevention of travellers' diarrhoea by Lactobacillus GG
18. Prophylactic efficacy of Lactobacilli on traveller's diarrhoea
19. Traveller's diarrhoea: Clinical presentation and prognosis
20. Prevention of traveller's diarrhoea: Comparison of different non-antibiotic preparations
21. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
22. Sympercents: Symmetric percentage differences on the 100 loge scale simplify the presentation of log transformed data
23. Lactobacillus reuteri as a therapeutic agent in acute diarrhoea in young children
24. Feeding of Bifidobacterium fibidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
25. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
26. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
27. Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener